Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

AIDS Reports

Much of the work carried out by DTT is in support of the National Toxicology Program (NTP), an interagency partnership of the Food and Drug Administration, National Institute for Occupational Safety and Health, and NIEHS.

Visit the NTP Website

These reports provide the findings and conclusions of studies of AIDS therapeutics conducted in rodents. The studies evaluated single therapeutic agents or combination therapies for effects on reproduction, general health, and the development of offspring.

Abstract Full Text Report Title Year Type
AIDS-09 AIDS-09 Full Report (5MB) NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Studies of 3'-Azido-3'-deoxythymidine (AZT) and Clarithromycin Combinations (CASRNs 30516-87-1 and 81103-11-9) Administered by Gavage to Swiss (CD-1®) Mice 2003 AIDS Therapeutics
AIDS-08 AIDS-08 Full Report (5MB) NIEHS Technical Report on the 13-Week Toxicity Study of 3'-Azido-3'-deoxythymidine (AZT) and Isoniazid Combinations (CASRNs 30516-87-1 and 54-85-3) Administered by Gavage to B6C3F1 Mice 2002 AIDS Therapeutics
AIDS-07 AIDS-07 Full Report (4MB) NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Study of 3'-Azido-3'-deoxythymidine (AZT) and Pyrazinamide Combinations (CASRNs 30516-87-1 and 98-96-4) Administered by Gavage to Swiss (CD-1®) Mice 2002 AIDS Therapeutics
AIDS-06 AIDS-06 Full Report (5MB) NIEHS Technical Report on the Subchronic Toxicity Study of 3'-Azido-3'-dioxythymidine (AZT) and Rifampicin Combinations (CASRNs 30516-87-1 and 13292-46-1) Administered by Gavage to B6C3F1 Mice 2001 AIDS Therapeutics
AIDS-05 AIDS-05 Full Report (2MB) NIEHS Technical Report on the Subchronic Toxicity Study of 3'-Azido-3'-dioxythymidine (AZT) and Pyrazinamide Combinations (CASRNs 30516-87-1 and 98-96-4) Administered by Gavage to B6C3F1 Mice 1999 AIDS Therapeutics
AIDS-04 AIDS-04 Full Report (6MB) NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Study of 3'-Azido-3'-deoxythymidine (AZT) and Rifabutin Combinations (CASRNs 30516-87-1 and 72559-06-9) Administered by Gavage to Swiss (CD-1®) Mice 2000 AIDS Therapeutics
AIDS-03 AIDS-03 Full Report (2MB) NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Studies of 3'-Azido-3'-dioxythymidine (AZT) and Isoniazid Combinations (CASRNs 30516-87-1 and 54-85-3) Administered by Gavage to Swiss (CD-1®) Mice 1999 AIDS Therapeutics
AIDS-02 AIDS-02 Full Report (4MB) NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Studies of 3'-Azido-3'-dioxythymidine (AZT), Trimethoprim (TMP)/ Sulfamethoxazole (SMX), and Folinic Acid Combinations Administered by Gavage to Swiss (CD-1®) Mice 1998 AIDS Therapeutics
AIDS-01 AIDS-01 Full Report (507KB) NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Studies of Pyrazinamide (CASRN 98-96-4) Administered by Gavage to Swiss (CD-1®) Mice 1997 AIDS Therapeutics
Back
to Top